B of A Securities analyst Kevin Fischbeck maintains UnitedHealth Group (NYSE:UNH) with a Buy and maintains $675 price target.
B of A Securities analyst maintains UnitedHealth Group (NYSE:UNH) with a Buy Read Post »
Mizuho analyst Vijay Rakesh maintains ARM Holdings (NASDAQ:ARM) with a Buy and raises the price target from $100 to $160.
Mizuho analyst maintains ARM Holdings (NASDAQ:ARM) with a Buy Read Post »
Mizuho analyst Vijay Rakesh maintains Broadcom with a Buy and raises the price target from $1450 to $1550.
Mizuho analyst maintains Broadcom with a Buy Read Post »
Mizuho analyst Vijay Rakesh maintains Advanced Micro Devices with a Buy and raises the price target from $200 to $235.
Mizuho analyst maintains Advanced Micro Devices with a Buy Read Post »
Ross Stores (ROST) better-than-expected fiscal Q4 earnings were due to topline and GM outperformance, Morgan Stanley said in a note to clients Wednesday. The EPS beat was partially offset by rising selling, general and administrative costs, however, the report added. Highlights of the quarter included underlying sales growth, current apparel category underperformance, fiscal Q4 GM reaching the highest level since 2017, and reducing the gap to its pre-Covid profitability levels, the report said. The off-price apparel and home fashion chain reported fiscal Q4 earnings late Tuesday of $1.82 per diluted share and sales of $6.02 billion for the quarter ended Feb. 3. Morgan Stanley raised Ross Stores’ price target to $161 from $155 and maintained its overweight rating on the stock.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Shares are ~3% lower in intraday trading on reports of Valisure’s, an independent U.S. laboratory, findings during testing of acne treatment products containing Benzoyl Peroxide (BPO). Valisure found BPO acne products are fundamentally unstable and can generate unacceptably high levels of Benzene, a known carcinogenic, when stored or exposed to higher temperatures by consumer handling. Benzene was found to potentially escape into the surrounding air at approximately 1,270 times the EPA’s calculated threshold for increased cancer risk, when measured in a compact car at 70 degrees Celsius. Clinique, one of EL’s leading brands, was highlighted as having BPO products. Visiting Clinique’s website we found 1/10 acne products listed BPO as an ingredient. This BPO acne product is not listed as a top-seller for Clinique across various e-commerce
CFRA Retains Hold Opinion On Shares Of The Estee Lauder Companies Inc. Read Post »
Target’s (TGT) merchandising and brand initiatives should help the retailer recapture traffic and share gains after reporting a strong fiscal Q4, BofA Securities said in an emailed note to clients Wednesday. The investment firm raised Target’s price target to $190 from $160 and reiterated its buy rating. Target faces steeper competition in same-day delivery as many large retailers also improved same-day offerings during the COVID-19 pandemic. Still, the company’s gross margin is expected to return to 6% operating margin in fiscal 2028, according to the note. “We continue to expect [gross margin] expansion in [fiscal year 2025] as well as a comp sales & traffic inflection in [fiscal Q2] driven by easing comparisons and the expected success of TGT’s merchandising initiatives,” BofA analysts said. “We expect these benefits to be partially offset by expense deleverage, particularly in Q1 as we forecast a comp sales decline of 4%.”
Target’s Merchandising, Brand Initiatives Should Support Traffic, Share Gains, BofA Says Read Post »
Tesla’s (TSLA) first-half results could come in below expectations on profitability amid a challenging year for electric vehicles, Morgan Stanley said in a report. “If there was ever a time for Tesla to potentially post a GAAP EBIT loss in the auto business, it may be this year,” Morgan Stanley said, pointing to decelerating EV demand in key markets and an over-supplied China EV market. Morgan Stanley expects Tesla to pull back on price cuts to defend its margins and cash flow in response to falling profitability. “However, we still forecast Tesla FY24 FCF of <$100mm for the year,” the report said. For FY2024, Morgan Stanley cut its GAAP EPS forecast for the company to $0.99 from $1.54 previously. Morgan Stanley reiterated its overweight rating on Tesla while lowering its price target to $320 from $345 amid the “seemingly overwhelming bearish institutional investor sentiment.” “Tesla has significant attributes to be
Tesla Faces Slowing Demand in Challenging Year, Morgan Stanley Says Read Post »
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $54 to $517, an 18.6x multiple of our 2024 EPS estimate (down by $0.05 to $27.80; we cut our 2025 estimate by $0.13 to $31.36), a premium to managed health care peers but below UNH’s historical average. A significant cyberattack on UNH’s Change Healthcare business (part of Optum) on February 21 continues to disrupt pharmacies, payments, and claims nationwide. Positively, UNH sees 90% of medical claims uninterrupted and expects to reach 95% next week. UNH also views pharmacy claims near normal volume. HHS released guidance from CMS encouraging workarounds such as removing prior authorizations and using alternative electronic data interchanges (EDI). We have seen shares other health care names like HCA Healthcare (HCA 323 ***) and Henry Schein (HSIC 76 ***)
CFRA Maintains Hold Opinion On Shares Of Unitedhealth Group Incorporated Read Post »
By Evie Liu Kroger’s earnings report set for Thursday comes at a time when the largest grocery operator in the U.S. is trying to further consolidate its market share to compete with Walmart and Costco Wholesale. For the fourth quarter ended Feb. 3, Wall Street expects sales to grow by 6.4% from a year ago to $37 billion, according to analysts polled by FactSet. Earnings are estimated at $1.13 per share, up 14% from the year-ago period. Prior to the fourth quarter of 2023, sales were lower than a year ago for two consecutive quarters, even though prices of most goods in grocery stores have gone up. Grocers are facing a tough environment. Consumers are dialing back spending amid inflation, while big-box chains like Walmart and Costco have been gaining market share in food retail as they leverage their size for cheaper prices. Meanwhile, e-commerce competitors like Amazon.com have disrupted
Kroger’s Earnings Are Coming. Merger Troubles Loom Large. — Barrons.com Read Post »
Morgan Stanley analyst Adam Jonas maintains Tesla (NASDAQ:TSLA) with a Overweight and lowers the price target from $345 to $320.
Morgan Stanley analyst maintains Tesla (NASDAQ:TSLA) with a Overweight Read Post »
CrowdStrike (CRWD.US) shares surged 23% in premarket activity on Wednesday after the company reported Q4 earnings that more than doubled from a year ago and the soaring revenue was ahead of the consensus. The company reported late Tuesday fiscal Q4 non-GAAP diluted earnings of $0.95 per share, up from $0.47 a year earlier. Analysts polled by Capital IQ expected $0.82. Revenue for the quarter ended Jan. 31 was $845.3 million, up from $637.4 million a year earlier. Analysts surveyed by Capital IQ expected $840.0 million. For fiscal Q1, the company expects non-GAAP diluted EPS of $0.89 to $0.90 on revenue of $902.2 million to $905.8 million. Analysts polled by Capital IQ expect $0.82 and $901.1 million, respectively. For fiscal 2025, it expects non-GAAP diluted EPS of $3.77 to $3.97 on revenue of $3.92 billion to $3.99 billion. Analysts in a Capital IQ survey are looking for $3.76 and $3.94 billion,